Curaleaf
| Company type | Public |
|---|---|
| Industry | Cannabis |
| Predecessor | PalliaTech |
| Founded | 2010 |
| Headquarters | New York City , United States |
Area served | North America, Europe |
Key people | Boris Jordan (Executive Chairman and CEO) |
| Products | Cannabis products including oils, chocolates, gummies, tinctures |
| Website | curaleaf |
Curaleaf Holdings, Inc. is a U.S.-based cannabis enterprise listed on the Canadian Securities Exchange with the ticker CURA. Established in 2010 and headquartered in New York City, Curaleaf ranks as the largest cannabis company worldwide by revenue, maintaining retail locations in 19 states across North America.
History
Initially launched as PalliaTech in 2010, the company commenced its activities in New Jersey while operating a research facility in Colorado. In 2013, Sputnik investment group acquired a 35% ownership stake. The company underwent rebranding to Curaleaf in 2018 prior to its initial public offering on the Canadian Securities Exchange, where it secured $400 million, marking the largest capital raise in the cannabis sector at that time.
Curaleaf’s expansion strategy has been notably aggressive, involving several acquisitions that broadened its market presence and diversified its product offerings. In 2019, it purchased Select, a prominent cannabis oil brand, which positioned Curaleaf as the leading cannabis operator in the United States. The subsequent year saw the acquisition of BlueKudu, a Colorado-based producer specializing in cannabis-infused chocolates and gummies. Additionally, in 2020, Curaleaf acquired Grassroots Cannabis, headquartered in Chicago, for $875 million, thereby extending its operations to 23 U.S. states and reinforcing its status as the top global revenue generator in the industry.
In April 2021, Curaleaf finalized the purchase of EMMAC Life Sciences Limited, recognized as Europe’s largest vertically integrated independent cannabis firm. This transaction expanded Curaleaf’s international footprint by adding cultivation facilities, EU GMP-certified processing capabilities, distribution networks, and research and development operations throughout key European markets such as the UK, Germany, Italy, Spain, and Portugal.
In May 2021, Curaleaf announced an agreement to acquire Los Sueños Farms, a 36-acre outdoor cultivation site located in Colorado with an estimated value exceeding $60 million.
September 2021 saw a product recall initiated by Curaleaf’s Oregon division after the Oregon Liquor and Cannabis Commission identified THC tinctures mistakenly labeled as CBD products.
In April 2023, Boris Jordan, Curaleaf’s Executive Chairman and CEO, was honored by Global Cannabis Times as one of the 100 Most Influential People in Business for his strategic contributions to the cannabis industry.